Status:
UNKNOWN
Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
Lead Sponsor:
Huashan Hospital
Conditions:
COVID-19
Eligibility:
All Genders
16-100 years
Brief Summary
Our project intends to independently develop a fully enclosed rapid detection system for a total of 22 pathogens, including SARS-CoV-2, on the basis of the QIAstat-Dx fully automatic multiple PCR dete...
Detailed Description
COVID-19 has not been well suppressed, and became a pandemic within 3 months globally is mainly because of the virus characteristic in the following aspects: 1. Long incubation period (average 5-7 da...
Eligibility Criteria
Inclusion
- Patients went to the fever clinic with respiratory infectious symptoms
Exclusion
- none
Key Trial Info
Start Date :
May 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04311398
Start Date
May 13 2020
End Date
December 1 2020
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200040